OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
January 29, 2021
The dispute between the European Commission (EC) of the European Union and pharmaceutical company AstraZeneca continues.
Although a necessity, companies must strike a critical balance between protecting innovations with IP and providing affordable access to medicines.
January 07, 2021
Intravacc and Cristal Therapeutics have entered into a strategic collaboration for the development of novel vaccine programs against human diseases.
January 05, 2021
Amid pressure to get more vaccines administered faster, FDA pushes back against changes in dosing regimens.
January 03, 2021
FDA approval rate speeds up despite COVID-19 complications.
The right partner can help companies overcome key formulation challenges for biologic drugs.
January 02, 2021
Shutting down the COVID-19 pandemic requires a global, selfless effort.
December 31, 2020
Administration of the COVID-19 vaccination from Oxford University and AstraZeneca is expected to begin in the UK in early 2021.
December 21, 2020
Moderna’s mRNA vaccine to prevent COVID-19 disease is granted FDA Emergency Use Authorization and CDC recommendation.
A decision by the European Commission on conditional marketing authorization for the European Union’s first COVID-19 vaccine is expected soon.